Description
A bioactive lipid produced by the sequential metabolism of anandamide by COX enzymes and PGD synthase; inactive against recombinant prostanoid receptors, including DP; increases the frequency of miniature inhibitory postsynaptic currents in hippocampal neurons; induces apoptosis in colorectal carcinoma cell lines
Formal name: N-(2-hydroxyethyl)-11-oxo-9α,15S-dihydroxy-prosta-5Z,13E-dien-1-amide
Synonyms: PGD2-EA|Prostamide D2
Molecular weight: 395.5
CAS: 398138-28-8
Purity: ≥96%
Formulation: A solution in ethanol
Product Type|Biochemicals|Lipids|Prostaglandins||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Neuroscience|Cannabinoid Research|Endocannabinoids